Resverlogix Corp.

Resverlogix Corp.

Resverlogix Corp.

RVX-208 is a first-in-class, selective BET bromodomain inhibitor treating patients with cardiovascular disease, diabetes mellitus, and other serious diseases.
Founded
2001
Raised
$67.3M
Follow us
Alexa global traffic share